Dena M. Carbonari - Concepedia

Author

Dena M. Carbonari

University of Pennsylvania ORCID

Also Known As

D Carbonari, D. M. Carbonari, Dean Carbonari, Dean M Carbonari, Dean M. Carbonari, Dena Carbonari, Dena M. Carbonari

Publications

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Kaiser Permanente Rutgers, The State University of New Jersey Wilmington University Philadelphia Fight

About

Dena M. Carbonari is an author at University of Pennsylvania specializing in medicine, hepatology, and acute liver failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	368
2	Public Health	3	3	161
3	Health Sciences	1	1	67
4	Management	1	1	127
5	Social Sciences	1	1	24

Dena M. Carbonari

Publications

951

Citations

H-Index

Page 1

	Year	Citations
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance Vincent Lo Re, Charitha Gowda, Paul Urick, Clinical Gastroenterology and Hepatology Health Insurance ReformPreventive MedicineHealth PolicyTreatment And PreventionAbsolute Denial	2016	127
Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System David S. Goldberg, Kimberly A. Forde, Dena M. Carbonari, Gastroenterology HepatologyPharmacoepidemiologyPatient SafetyOutcomes ResearchPharmacotherapy	2015	111
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status Vincent Lo Re, Dena M. Carbonari, James D. Lewis, The American Journal of Medicine Antifungal AgentHepatologyMedicineLiver PhysiologyAntifungal Agents	2015	90
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study Charitha Gowda, Stephen Lott, Matthew Grigorian, Open Forum Infectious Diseases	2018	74
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients Vincent Lo Re, Sarah K. Dutcher, John G. Connolly, JAMA	2022	74
Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model Vincent Lo Re, Kevin Haynes, Kimberly A. Forde, Clinical Gastroenterology and Hepatology HepatologyLiver PhysiologyNew Prognostic ModelPatient SafetyDrug Toxicity	2015	67
Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America H. Nina Kim, Craig Newcomb, Dena M. Carbonari, Hepatology	2021	58
Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini‐Sentinel Distributed Database Vincent Lo Re, Kevin Haynes, David S. Goldberg, Pharmacoepidemiology and Drug Safety	2013	57
Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection Dana Byrne, Craig Newcomb, Dena M. Carbonari, Journal of Hepatology Viral HepatitisHepatitis BHepatitisChronic Viral InfectionMedicine	2014	30
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status Jessie Torgersen, Michael J. Kallan, Dena M. Carbonari, JNCI Journal of the National Cancer Institute	2019	29

Page 1